Six1 promotes epithelial-mesenchymal transition and malignant conversion in human papillomavirus type 16-immortalized human keratinocytes

Carcinogenesis

Volumn 35, Issue 6, 2014, Pages 1379-1388

  Xu, Hanwen ^a   Zhang, Yu ^b   Altomare, Diego ^a   Peña, Maria M ^c   Wan, Fang ^c,d   Pirisi, Lucia ^c   Creek, Kim E ^a  

^a University of South Carolina   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD PROTEIN; TRANSCRIPTION FACTOR SIX1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; HOMEODOMAIN PROTEIN; SIX1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CELL INVASION; CELL POPULATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; MALIGNANT TRANSFORMATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; UPREGULATION; UTERINE CERVIX CANCER; ANIMAL; CELL TRANSFORMATION; CLUSTER ANALYSIS; DISEASE MODEL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSFORMED CELL LINE; TUMOR CELL LINE; TUMOR VOLUME; VIROLOGY; VIRUS CELL TRANSFORMATION; XENOGRAFT;

ANIMALS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HELA CELLS; HETEROGRAFTS; HOMEODOMAIN PROTEINS; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATINOCYTES; MAP KINASE SIGNALING SYSTEM; MICE; NEOPLASTIC STEM CELLS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TUMOR BURDEN;

EID: 84905373495     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu050     Document Type: Article

References (49)

1. Peralta-Zaragoza, O. et al. (2012) Targeted treatments for cervical cancer: a review. Onco. Targets. Ther., 5, 315-328.
2. Saslow, D. et al.; ACS-ASCCP-ASCP Cervical Cancer Guideline Committee. (2012) American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Cancer J. Clin., 62, 147-172.
3. Pirisi, L. et al. (1988) Continuous cell lines with altered growth and differentiation properties originate after transfection of human keratinocytes with human papillomavirus type 16 DNA. Carcinogenesis, 9, 1573-1579.
4. Pirisi, L. et al. (1987) Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J. Virol., 61, 1061-1066.
5. Wan, F. et al. (2008) Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer. Int. J. Cancer, 123, 32-40.
6. Zheng, W. et al. (2003) The role of Six1 in mammalian auditory system development. Development, 130, 3989-4000.
7. Ikeda, K. et al. (2010) Six1 is indispensable for production of functional progenitor cells during olfactory epithelial development. Int. J. Dev. Biol., 54, 1453-1464.
8. Xu, P.X. et al. (2003) Six1 is required for the early organogenesis of mammalian kidney. Development, 130, 3085-3094.
9. Coletta, R.D. et al. (2008) Six1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformation. Cancer Res., 68, 2204-2213.
10. Behbakht, K. et al. (2007) Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival. Cancer Res., 67, 3036-3042.
11. Zheng, X.H. et al. (2010) Expression and clinical implications of homeobox gene Six1 in cervical cancer cell lines and cervical epithelial tissues. Int. J. Gynecol. Cancer, 20, 1587-1592.
12. Ng, K.T. et al. (2010) Suppression of tumorigenesis and metastasis of hepatocellular carcinoma by shRNA interference targeting on homeoprotein Six1. Int. J. Cancer, 127, 859-872.
13. Christensen, K.L. et al. (2008) The six family of homeobox genes in development and cancer. Adv. Cancer Res., 101, 93-126.
14. Micalizzi, D.S. et al. (2010) Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth. Cancer Res., 70, 10371-10380.
15. Micalizzi, D.S. et al. (2009) The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling. J. Clin. Invest., 119, 2678-2690.
16. Tan, J. et al. (2011) Expression and significance of Six1 and Ezrin in cervical cancer tissue. Tumour Biol., 32, 1241-1247.
17. Wettenhall, J.M. et al. (2004) limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics, 20, 3705-3706.
18. Ritchie, M.E. et al. (2007) A comparison of background correction methods for two-colour microarrays. Bioinformatics, 23, 2700-2707.
19. Dai, J.L. et al. (1998) Dpc4 transcriptional activation and dysfunction in cancer cells. Cancer Res., 58, 4592-4597.
20. Schock, F. et al. (2002) Molecular mechanisms of epithelial morphogenesis. Annu. Rev. Cell Dev. Biol., 18, 463-493.
21. Noordhuis, M.G. et al. (2011) Involvement of the TGF-beta and betacatenin pathways in pelvic lymph node metastasis in early-stage cervical cancer. Clin. Cancer Res., 17, 1317-1330.
22. Kowli, S. et al. (2013) TGF-β regulation of gene expression at early and late stages of HPV16-mediated transformation of human keratinocytes. Virology, 447, 63-73.
23. Wendt, M.K. et al. (2009) Mechanisms of the epithelial-mesenchymal transition by TGF-beta. Future Oncol., 5, 1145-1168.
24. Meulmeester, E. et al. (2011) The dynamic roles of TGF-β in cancer. J. Pathol., 223, 205-218.
25. Zhang, Y.E. (2009) Non-Smad pathways in TGF-beta signaling. Cell Res., 19, 128-139.
26. Mani, S.A. et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133, 704-715.
27. Meng, E. et al. (2012) CD44+/CD24-ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival. Clin. Exp. Metastasis, 29, 939-948.
28. Sheridan, C. et al. (2006) CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res., 8, R59.
29. Gu, W. et al. (2011) Silencing oncogene expression in cervical cancer stemlike cells inhibits their cell growth and self-renewal ability. Cancer Gene Ther., 18, 897-905.
30. Rao, Q.X. et al. (2012) Expression and functional role of ALDH1 in cervical carcinoma cells. Asian Pac. J. Cancer Prev., 13, 1325-1331.
31. Yao, T. et al. (2011) The expression of ALDH1 in cervical carcinoma. Med. Sci. Monit., 17, HY21-HY26.
32. Coletta, R.D. et al. (2004) The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1. Proc. Natl Acad. Sci. USA, 101, 6478-6483.
33. Li, Z. et al. (2013) Six1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression. PLoS One, 8, e59203.
34. Baritaki, S. et al. (2007) Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection. Int. J. Oncol., 31, 69-79.
35. Bhowmick, N.A. et al. (2001) Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J. Biol. Chem., 276, 46707-46713.
36. Galliher, A.J. et al. (2007) Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res., 67, 3752-3758.
37. Buck, M.B. et al. (2006) TGF-beta signaling in breast cancer. Ann. N. Y. Acad. Sci., 1089, 119-126.
38. Jiang, F. et al. (2002) Fibronectin-and protein kinase C-mediated activation of ERK/MAPK are essential for proplateletlike formation. Blood, 99, 3579-3584.
39. Shipitsin, M. et al. (2007) Molecular definition of breast tumor heterogeneity. Cancer Cell, 11, 259-273.
40. Galliher, A.J. et al. (2006) Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Res., 8, R42.
41. Lavoie, J.N. et al. (1996) Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem., 271, 20608-20616.
42. Yoshino, Y. et al. (2006) Activation of p38 MAPK and/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells. Int. J. Oncol., 29, 981-987.
43. Kim, M.S. et al. (2003) p38 kinase is a key signaling molecule for H-Rasinduced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res., 63, 5454-5461.
44. Chen, L. et al. (2009) Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells. Cancer Res., 69, 8853-8861.
45. Lin, S.P. et al. (2012) Survival of cancer stem cells under hypoxia and serum depletion via decrease in PP2A activity and activation of p38-MAPKAPK2-Hsp27. PLoS One, 7, e49605.
46. Wagner, E.F. et al. (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer, 9, 537-549.
47. Minn, A.J. et al. (2005) Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Invest., 115, 44-55.
48. Minn, A.J. et al. (2007) Lung metastasis genes couple breast tumor size and metastatic spread. Proc. Natl Acad. Sci. USA, 104, 6740-6745.
49. Bos, P.D. et al. (2009) Genes that mediate breast cancer metastasis to the brain. Nature, 459, 1005-1009.